Now, when you search Google for something which includes the word 'job' or 'jobs', Google presents an easy-to-filter list of local vacancies. You can also search in other locations.
One of the criteria for a job advert to be listed in Google for Jobs is that it must first have appeared on a webpage written with special code which allows the search engine to read the advert correctly.
VetSurgeon Jobs has been upgraded to include this code, and jobs advertised on VetSurgeon.org are now appearing on Google for Jobs.
VetSurgeon Editor Arlo Guthrie said: "We've known this was coming for some time, so we made sure VetSurgeon Jobs would be ready as soon as Google unveiled the new system.
"It has yet to be seen how widely Google for Jobs will be used by veterinary surgeons looking for a job. Back in the day, you'd have to wait for the latest copy of Vet Times to arrive in the post in order to find a job. Then came the internet, and with it a small handful of job websites worth checking for veterinary vacancies, of which VetSurgeon Jobs is one.
"Now, Google for Jobs provides one-stop search from most of the big players, although not all veterinary job boards are compatible with the new system and notably Indeed is excluded from Google for Jobs search results.
"The question now is whether jobseekers will continue to go directly to their favourite job website, or search Google first. Either way, though, you'll find jobs advertised on VetSurgeon.org!"
What do you think of the new Google for Jobs feature? Comment below.
505 people took part in the survey in August 2019, of which 85% were receptionists. The remainder were RVNs, VCAs or practice managers with some front desk responsibility.
The survey found that 45% were paid between £8 and £9 per hour, with 9% more falling into this salary bracket than in 2018. 5.32% were paid £8 or less per hour.
The Real Living Wage is a figure calculated from the costs of a basket of household goods and services by the Living Wage Foundation, and voluntarily paid by its 6000-odd member companies in the UK. The Living Wage Foundation argues it is a better measure of what people need to get by on than the Minimum Wage (£7.70 for those aged between 21 and 25) or the National Living Wage (£8.21 for those over 25).
63% of veterinary receptionists said they were unsatisfied with their pay. However, it was not the biggest cause of dissatisfaction uncovered by the survey. 67% were dissatisfied with the recognition of the value of their role, and 69% with the career progression options open to them.
70% of respondents said they would like to do more CPD and that the main benefit would be to clients and patients. However, 43% of receptionists said there is no time allowance set aside for them to complete CPD.
Co-founder of BVRA and Honorary Associate Professor In Veterinary Business, Nottingham University, Brian Faulkner (pictured right) said: "A large part of the client experience is centred around the waiting room and receptionist area and our members work hard to ensure that experience is positive.
"We have an increasing number looking to upskill and the appetite for CPD is clearly there. If we can envisage a scenario where the minimum wage is set at £10.50 an hour, that would mean that around 65% of veterinary receptionists would need a pay increase.
"I don't think any of us believe that veterinary receptionists are currently doing an unskilled job and a key mission of BVRA is to achieve greater recognition of the value they bring to practices, both as colleagues and commercially."
If you buy 12 bags from the listed Veterinary Care Nutrition and Satiety Range, you'll get three outers of feline wet food free. Order a minimum of 12 bags and you'll also get a free standing display unit, twelve 50th Anniversary tins and a 50th Anniversary promotional pack. If you buy another eight bags from the listed Canine and Feline Veterinary Care Nutrition and Clinical range, you'll get one box of 12 Anniversary Tins free.
The 50th anniversary promotion pack includes bunting, a window cling, bag stickers and posters.
Erin Biss, Marketing Executive at Royal Canin, said: "50 years on, we continue to put science at the heart of everything we do. From our specially developed diets, to investment in education, supporting important research projects and collaborating with the UK’s universities. We hope vet practices around the UK will join us in celebrating this milestone.”
For more information about Royal Canin's 50th anniversary offer, speak to your Veterinary Business Manager.
The pads contain ophytrium and chlorhexidine at 3%. Ophytrium is a purified natural ingredient from Ophiopogon japonicus which, Ceva says, strengthens the mechanical skin barrier1, restores the balance of protective microbial flora2 and reduces irritation, while soothing the skin1. Chlorhexidine is both antibacterial and antifungal.
Ceva says that Douxo S3 Pyo pads, which come in packs of 30, provide antibacterial and antifungal efficacy within one minute and are free from soap, parabens, sulphates, phthalates, colourants and nanoparticles.
They are available in a new, hypoallergenic ‘summertime’ fragrance which pet owners liken to coconut and vanilla.
The pads add to the Douxo S3 Pyo range, which also consists of shampoo and a mousse.
Andrew Fullerton BVSc (Hons) MRCVS, product manager for Douxo S3 at Ceva said: "The new Douxo S3 range has been well received by both veterinary professionals and their clients since its launch, who find that the products are not only effective and well tolerated, but also easy-to-use. The Douxo S3 Pyo pads will enhance this range by offering an easy-to-administer antiseptic action while hydrating and maintaining the skin’s ecosystem.”
For further information, contact cevauk@ceva.com, your local territory manager or visit https://www.douxo.com/uk/Pet-Skin-Care/douxo-s3.
References
The researchers say that ultimately the study should help with the development of guidelines to help all riders assess if they are the right weight for the horse or pony they intend to ride, to enhance both equine welfare and rider comfort and enjoyment.1
Dr Sue Dyson, Head of Clinical Orthopaedics at the Animal Health Trust’s Centre for Equine Studies, Newmarket, who led the study said: "While all the horses finished the study moving as well as when they started, the results showed a substantial temporary effect of rider weight as a proportion of horse weight.
"The results do not mean that heavy riders should not ride but suggest that if they do they should ride a horse of appropriate size and fitness, with a saddle that is correctly fitted for both horse and rider.
"We must remember that this is a pilot study: further work is required to determine if horse fitness, adaptation to heavier weights and more ideal saddle fit will increase the weight an individual horse can carry. This should help us further in our quest to develop guidelines for optimum rider: horse bodyweight ratios."
As the average weight and height of humans continues to increase there is growing debate about relative rider-horse sizes, with riding school horses epitomising the variety of weights of rider that a single horse may be exposed to.
Numerous inter-related aspects are involved with the horse and rider combination including the age of the horse, its fitness and muscle development, the length of its back and the presence or absence of lameness. The rider’s skill, fitness, balance and coordination are important factors, as is the fit of the saddle to both the horse and rider. The type, speed and duration of work and the terrain over which the horse is ridden must also be considered.2
To date little research has been conducted on the effects of rider weight on equine welfare and performance. To address the shortfall World Horse Welfare, the Saddle Research Trust, the British Equestrian Federation and a number of other organisations helped to fund a pilot study last summer, the results of which have now been analysed.
The influence of rider to horse bodyweight ratios on equine gait and behaviour: a pilot study1 assessed gait and behavioural responses in six horses ridden by four riders of similar ability but different sizes. The riders were all weighed in their riding kit and were subsequently categorised as being light, moderate, heavy and very heavy. Their body mass index (BMI) was also calculated.
Each rider rode each horse in its usual tack and performed a set pattern of exercises comprising mainly trot and canter. Gait, horse behaviour, forces under the saddle, the response to palpation of the back, alterations in back dimensions in response to exercise, heart and respiratory rates, salivary cortisol levels and blink rate were assessed for each combination.
The riding tests for the heavy and very heavy riders were all abandoned, predominantly because of temporary horse lameness. This was likely to have been induced by bodyweight rather than BMI, given that the heavy and moderate riders had similar BMIs, both being classified as overweight, yet only one of the moderate rider’s tests had to be abandoned. An ethogram, developed by Dr Dyson specifically to assess behavioural markers which may reflect pain in ridden horses3, was applied. The scores which may reflect pain were significantly higher in the horses when ridden by the heavy and very heavy riders.
The study also raised the issue of rider height and saddle fit. The owner of one of the test horses had a similar bodyweight: horse bodyweight ratio to the heavy rider and was of similar weight, but significantly different in height (157.0 and 185.5 cm, respectively). This large difference in height has major potential implications for saddle fit for the rider and consequently the rider’s position and weight distribution. The taller rider sat on the back of the cantle, overloading the back of the saddle and making it more difficult to ride in balance, with the heel being in front of a vertical line between the shoulder and ‘hip’.
Roly Owers, Chief Executive of World Horse Welfare, said: "These pilot results are certainly not surprising but are very significant in adding vital evidence to inform an appropriate rider: horse weight ratio. It is common sense that rider weight impacts equine welfare however many might not fully understand or recognise this. What is desperately needed is basic guidance to help riders identify a horse or pony that is right for them and this research is a vital step in that direction.”
The study was generously supported by World Horse Welfare, the Saddle Research Trust, Frank Dyson, British Equestrian Federation, British Horse Society, Pony Club, Polocross, The Showing Council, The Showing Register, The Society of Master Saddlers, Riding for the Disabled, British Eventing, British Dressage, the British Horse Foundation, the Worshipful Company of Saddlers and Endurance GB.
Chanelle's head of sales and marketing, Killian Gaffney said: "The total UK market is around 80,000 bottles annually. However, with the major supplier announcing some re-stocking in March but full availability still under question, there is a real sense of urgency for practitioners.
"The Chanelle team worked throughout December with our manufacturing division to ensure that the UK product shortfall could be alleviated.
"Air freighting supplies seemed the obvious course of action, and ensured we could supply the UK market as quickly as possible."
For further information, contact: Chanelle on 00353 91 841 788.
The article looks at the practice, rationale and motivation for raw feeding before evaluating the existing evidence on both the benefits and risks of such diets.
The recent trend away from heat-treated, manufactured pet food for dogs and cats towards raw diets has been driven by suspicion of the former and perceived health benefits of the latter.
However, feeding raw diets, even commercially-prepared ones, does have risks: a recent paper described 13 cats in the UK that appeared to have been infected by Mycobacterium bovis2 by feeding Natural Instinct Wild Venison, a commercial raw mince for cats.
The leader of the investigation, Professor Danièlle Gunn-Moore from the University of Edinburgh said: "Feeding raw food was the only conceivable route of infection in most cases; this outbreak of tuberculosis has now affected more than 90 individuals in over 30 different locations, with more than 50 of the cats developing clinical disease."
One of the authors of the review, Dr Andrew Wales, said: "Formal evidence does exist for claims by raw‐feeding proponents of an altered intestinal microbiome and (subjectively) improved stool quality. However, there is currently neither robust evidence nor identified plausible mechanisms for many of the wide range of other claimed benefits.
"There are documented risks associated with raw feeding, principally malnutrition (inexpert formulation and testing of diets) and infection affecting pets and/or household members. Salmonella has been consistently found and there is also a risk of introducing antimicrobial-resistant bacteria."
The full review article can be found in the June issue of the Journal of Small Animal Practice which is free for BSAVA members. It can also be read online here https://onlinelibrary.wiley.com/doi/10.1111/jsap.13000
For the study1, treatment and outcomes of ureter injuries due to ovariohysterectomy complications in cats and dogs was undertaken at the Royal Veterinary College. A retrospective case series of cats and dogs with ureteric injuries resulting from ovariohysterectomy was obtained from patient records at the Queen Mother Hospital for Animals. Fourteen female cats and five female dogs were included in the analysis. Descriptive statistics were used to report presenting clinical signs, clinical pathology, treatment and outcomes.
Professor Vicky Lipscomb, lead author of the paper, said “Presenting clinical signs of ureter injury following neutering in this study were non-specific, such as anorexia, vomiting and lethargy. Importantly, the clinical signs consistently developed immediately or shortly after surgery in the majority of animals. Therefore, the appearance of one or more clinical signs following neutering should raise suspicion of a neutering complication.
"The overall outcome for the 19 animals was excellent in 13 (68%), good in one (5%), fair in one (5%) and poor in four (22%). Ureteroneocystostomy (ureteral re-implantation) is preferred to ureteronephrectomy (removal of kidney and ureter) to preserve renal function and is usually a requirement for bilateral ureteric injuries but carries a high complication rate resulting in additional surgery, albeit often with an excellent final outcome.”
Nick Jeffery, editor of JSAP said: “Ovariohysterectomy is a common surgical procedure in cats and dogs, but the procedure carries a (low) risk of injury to one or both ureters due to the close proximity of the female reproductive tract and the ureters. This research highlights the need for vigilance regarding clinical signs following neutering but demonstrates that surgical treatment of ureteric injuries can have good patient outcome."
The full article can be found in the March issue of the Journal of Small Animal Practice which is free for BSAVA members. It can also be read online here: https://onlinelibrary.wiley.com/doi/10.1111/jsap.13100
Reference
Photo: Luisa Dormer BSAVA
Dechra says phenobarbital is effective as a monotherapy in 60 to 80 per cent of dogs with idiopathic epilepsy, but that in 40% of dogs, seizures cannot be controlled with phenobarbital alone. In these cases the company's potassium bromide treatment Libromide, is licensed to be used alongside Soliphen as a concurrent therapy.
According to the company, the combination of phenobarbital and potassium bromide has been shown to reduce seizure number and severity in dogs with refractory idiopathic epilepsy; in tests, the combination treatment reduced the mean seizure rate from 27.4 seizures per month to 2.2 seizures.
Dechra Veterinary Products Brand Manager Craig Sankey said: "Epilepsy is the most common chronic canine neurological disorder, affecting around 0.62 per cent of dogs.
"It can be a distressing condition for both the animal and its owner so we are launching a therapy that can reduce the number of seizures in even the most challenging cases.
"We have also produced new guidelines for prescribing vets, detailing step by step how the treatments can act alone or concurrently. We believe using Soliphen as a sole therapy or in conjunction with Libromide will make a positive contribution to veterinary professionals in their ongoing treatment and management of dogs with epilepsy."
For more information, visit www.dechra.co.uk
According to the company, a similar percentage of respondents believe that senior cats would benefit clinically if they monitored blood pressure routinely in their senior years, and nearly 85% said that anti-hypertensive medication would increase the quality of life for their patients.
Time constraints were cited as the main barrier to routinely measuring blood pressure, but all of those questioned would be happy for a trained RVN to measure blood pressure in cats.
Ceva highlights studies which show show that hypertension affects one in eight cats over nine years old3, with the risk increasing as cats age or if they have other conditions such as chronic kidney disease (where one in three cats suffer with hypertension) or overactive thyroid disease (where an estimated one in four cats suffer with hypertension)4, 5, 6.
Rosanne Jepson, specialist in small animal internal medicine at the Royal Veterinary College said: "High blood pressure can cause severe damage to key body organs including the eyes, kidneys, heart and brain. Unfortunately, it is a condition that develops insidiously without early warning signs for the cat owner; a cat may seem perfectly fine until either the blood pressure is checked, or serious consequences of hypertension suddenly occur."
With this in mind, Ceva says it will host the first Feline Hypertension Month this May, to raise awareness of hypertension and improve the detection and management of high blood pressure in cats.
The company is also encouraging practices to take part in the 'Mercury Challenge', a study it is launching in the summer which will, it says, be the largest-ever European study into feline hypertension.
For information on feline hypertension, Feline Hypertension Month or the Mercury Challenge, contact your local Ceva Animal Health account manager.
On Tuesday 8th September Dr Owen Davies, an RCVS and American Specialist in Veterinary Oncology, will present ‘Mast Cell Tumours: An Update’, in which he will review mast cell tumours and diagnostic approaches before appraising the current treatment options.
On Wednesday 9th September Dr Pam Jones, a double board certified Specialist in Veterinary Medical Oncology and Radiation Oncology from the US, will present ‘Stelfonta: Seeing is Believing’.
Dr Jones will introduce delegates to the unique mode of action of tigilanol tiglate, review the efficacy data behind the new product and demonstrate how this treatment can be used to provide a high tumour elimination rate, wound healing and a speedy return to a good quality of life for the pet.
Dr Neil Mottram, Technical Product Manager at Virbac said: “The effects of Stelfonta really do need to be seen to be believed, so we’re excited to offer vets the opportunity to learn more about this ground-breaking advancement in veterinary oncology. We are lucky to have secured some fantastic speakers for the webinars so delegates can be assured of some top quality CPD.”
Both events will be hosted by The Webinar Vet and begin at 7:30pm. Registration for the event is now open and can be found at www.thewebinarvet.com/stelfonta
For more information, speak to your Virbac Territory Manager or visit vet-uk.virbac.com/stelfonta
The nurse, who admitted the charges against her, successfully applied for anonymity at the outset of the case, on the basis that the shock factor of the removal of the animals' heads could greatly upset members of the public and veterinary staff, leading to a backlash which would present a threat to her safety.
The Disciplinary Committee heard that the nurse, who was working as a locum, asked a permanent member of staff if she could take a couple of skulls from the strays, because she had a friend who 'cleaned up' dead strays and wildlife and displayed the skulls at home.
The College’s case was that the nurse’s actions amounted to serious professional misconduct because she failed to afford the dead animals with the respect and dignity they deserved, there was a risk to human health because she failed to comply with biosecurity measures, and her actions had the potential to undermine public confidence in the profession.
Although she admitted that her conduct fell short of what was expected, the nurse countered that her actions were not intended to be disrespectful to the animals, that she was an animal-lover who had three cats of her own, and that her actions were not malicious but misjudged.
Weighing up the case, the Committee found that the aggravating features of her conduct were around biosecurity and abuse of her professional position, while in mitigation it found that there was no financial gain in her actions and that it was a one-off incident.
Kathryn Peaty, chairing the Committee and speaking on its behalf, said: “The respondent’s conduct represented a biosecurity risk.
"Any body part would be in some degree of decomposition.
"As the cats were strays, it was unclear as to whether or not they had been in good health.
"Although the respondent transferred the body parts to her home and kept them in the freezer in cadaver bags, there was a risk that they could leak.
"In short, her actions were not without risk to human or animal health.
“The respondent abused her professional position.
"She had an obligation to treat the cadavers with respect.
"Her professional position gave her access to the cadavers.
"She abused her professional position by severing the cats’ heads and, using a scalpel, body bags and other equipment she pursued an interest of her own, rather than performed the role she was employed to undertake.
"Although she may say that she obtained permission to remove the cats’ heads from a permanent member of staff, she was a Registered Veterinary Nurse and therefore an autonomous professional.
"Whatever permissions she received should not have made her believe she had a licence to act as she did.”
Considering the appropriate sanction, the Committee took into account her relative youth and inexperience, the fact she made open and frank admissions at an early stage, the fact she made efforts to avoid a repetition of the behaviours, the insight she had shown into why her conduct was wrong, and the amount of time that had passed since her conduct relative to the total length of her four-year veterinary nursing career.
The Committee also considered positive character references from fellow veterinary nurses with whom she worked and trained.
Kathryn added: “The Committee considered that a reprimand was the sanction it should impose.
"A reprimand marks the Committee’s view of the respondent’s behaviour, thereby satisfying the public interest.
“The Committee did consider issuing a warning as to future conduct, but it had no concerns that the respondent would fail to follow the Code of Professional Conduct for Veterinary Nurses in the future.
"It therefore rejected a warning as an appropriate alternative.”
The full findings of the Disciplinary Committee can be found at www.rcvs.org.uk/disciplinary
The Prince's Trust 'creates life-changing opportunities' for those aged 11-30 and Nick has long-held a passion for making a difference to young lives. He has set up three charities for young people: with learning disabilities; who want to campaign to change the world; and who want to break down the barriers to enjoying nature and the outdoors.
Nick has led the RCVS since September 2012. During his tenure, developments at the College include a new Royal Charter, major governance reform, improved regulation of veterinary nurses, the instigation of Vet Futures, the introduction of the alternative dispute resolution service, significant evolution within the Practice Standards Scheme, the refocusing of RCVS Trust into RCVS Knowledge, the launch of Mind Matters, and the recognition of the College as a Great Place to Work.
Nick said: "It has been a great privilege to be CEO of the College and to work with such amazing staff, such a progressive Council and such a decent and caring profession. It is no surprise to me that vets and vet nurses are among the most trusted professionals in this country, and in my view this is due to their professionalism and to the excellence of the Royal College in maintaining and advancing standards. I hope I have played my part in helping the College and the profession navigate through a period of great change and preparation for significant change to come.
"At The Prince’s Trust I will be focused on the next generation, helping to give young people the confidence and purpose they need to make a success of their lives and the world around them. I know from my own personal experiences of school, and the various charities with which I have been involved, how many young people are not given the best chance in life. I cannot think of a better mission to take on."
RCVS President Chris Tufnell said: "I feel very fortunate to have worked closely with Nick over his five years with the RCVS; he has made a tremendous contribution to the College and our professions. With his energy and drive, he has infused the College with a culture of openness, engagement and dedication and has inspired the team through some impressive achievements.
"Nick’s leadership will enable vets and veterinary nurses to fulfil their potential and it's fitting that he's moving on to a role which benefits the lives of others. Meanwhile, there's a considerable amount of important work being done by the RCVS and I am confident that we have a strong team at Belgravia House to manage this until the new CEO is in post."
The RCVS says its Operational Board will be reflecting on Nick’s successes and the future needs of the College, before developing a specification for the new CEO and a recruitment process over the coming weeks.
The review was recommended to Council by its Standards Committee following its exploration of the implications of new technologies for both animal health and welfare and veterinary regulation.
The main areas under consideration are the interpretation and application of an animal being under the care of a veterinary surgeon, and the provision of 24-hour emergency cover.
The College says that during the course of its research, which included numerous meetings and reports, a public consultation and examination of external legal advice, the Committee identified a number of anomalies in the College’s existing guidance that could affect how the Code’s provisions were applied across a range of different scenarios.
Chair of the Standards Committee, Dr Kate Richards, said: "It became clear to us that we could not consider telemedicine and remote prescribing in isolation and that it raised broader questions around the appropriateness of, and justification for, certain elements of existing RCVS guidance. I’m therefore pleased that RCVS Council has decided that the right and responsible approach is first to conduct a full review of these provisions."
The College anticipates that the review will require wide engagement from all relevant sectors, potentially including a Select Committee-style hearing in certain areas. This, it says, would help to ensure any decision to treat different groups differently, in relation to 'under care' and 'out-of-hours', is both reasoned and justified.
In the meantime, the College says that the current provisions of the RCVS Code of Professional Conduct and its supporting guidance remain in full effect.
Further information about the review will be made available in due course.
UPDATE (19/06/2019)
Following a number of concerns raised by members of the profession about this story, the RCVS has issued a further statement as follows:
We would like to acknowledge and address a number of concerns that have arisen amongst the profession following RCVS Council’s discussion last week that followed up queries raised during the previous debate in November, around the provision of telemedicine services, including remote prescribing.
The RCVS Council decision, made unanimously, was to proceed with a wide-ranging review of RCVS supporting guidance concerning 24-hour emergency cover and the interpretation and application of ‘under veterinary care’, and to postpone the proposed telemedicine trial for the foreseeable future and certainly until the conclusion of this review. The review will encompass, but not be limited to, consideration of what restrictions or safeguards to place on remote prescribing in the form of vet-to-client telemedicine.
RCVS Council discussed this paper ‘in committee’ in order to be able to examine the confidential legal advice it had requested at its previous meeting. The decision to hold these discussions privately was purely related to the privileged nature of legal advice and in no way related to any ‘commercial interests’.
We recognise fully that this is a complex issue, with strong views held on all sides. However, it is entirely right and proper for RCVS Council members to be able to discuss and debate such topics in detail, before reaching a decision through a vote. In the course of such discussions, issues may arise that had not previously been identified, and which may alter the original direction of thinking.
We appreciate that Council’s decision was perhaps unexpected, especially as the original topic had been under consideration for some time. This is why we announced it as soon as possible, along with an indication of what Council would like to happen next.
Whilst it is far too early to have worked out the details of the agreed review, it will be open and inclusive in parallel with our previous consultations, which continue to receive considerable levels of engagement across the veterinary professions and wider industry stakeholders.
We will publish full details about our plans for this review over the coming weeks, and will continue to work hard to engage all veterinary professionals in these important decisions.
Ceva Animal Health has launched Hepatosyl Plus, a development of the liver support supplement for cats and dogs.
Hepatosyl Plus contains the same ingredients as the original product but now also includes Silybin. According to the company, Silybin is the most active isomer of Silybum marianum (milk thistle) which acts as an antioxidant by increasing cellular superoxide dismutase. It joins S-adenosylmethionine (SAMe) and Vitamin E to create a triple antioxidant approach to liver support, helping to neutralise free radicals within the liver. Ceva also says Hepatosyl Plus is the only liver supplement to contain Vitamin K, which is needed by the liver for the production of clotting factors II, VII, IX and X, making it ideally suited for pre- and post-anaesthetic liver support.
Hepatosyl Plus is available in 50mg, 100mg and 200mg sprinkle capsules. For anaesthetic support, Hepatosyl Plus should be administered for one week prior to and following anaesthesia. For long-term use, the capsules should be given once daily for 2-3 months and then reduced to every other day for ongoing maintenance.
For further information, please contact your local CEVA Animal Health territory manager or call 01494 781510.
Ceva says the new product is the fruit of research into the composition of the main feline pheromones which pass through the incisive ducts to the Vomeronasal Organ (VNO), which in turn led to the discovery of a new pheromone complex which 'provides an enhanced message of social confidence and safety in the cat’s environment by conveying more impactful messages to it'.
According to the company, Feliway Optimum helps cats with more signs of stress, in more situations and calms cats better than ever. The product is proven to help with more stress-related signs faster than existing pheromones, with all signs of stress showing continuous improvement until day 28 of use and are visible from day 71. These include scratching, urine spraying, multi-cat tensions and conflicts and changes and fears.
Feliway Optimum is available as a plug-in diffuser with 30-day refills.
Abigail King, senior behaviour product manager at Ceva Animal Health said: "We have led the way with research for over 20 years with Feliway Classic and Feliway Friends, but it is now time to go that step further.
"Feliway Optimum is an extremely exciting addition to the range which will help solve all common signs of stress to provide enhanced serenity in a household.
"Nearly 60 per cent of cats show visible signs of stress2 and Feliway Optimum will really help combat this with an over 70% reduction”.
There is a webinar about the new product, presented by Professor Patrick Pageat and Dr Andy Sparkes, which is available by emailing Ceva.
For more information, visit www.feliway.com/uk, call Ceva on 01494 781510 or email cevauk@ceva.com.
In a European first, Pfizer Animal Health is conducting a major study in over 2000 dogs with Trocoxil, its new NSAID which delivers continuous analgesia for a month.
According to the company, Trocoxil has already been granted a licence by the EMEA and pre-authorization studies have already shown once-monthly Trocoxil to be at least as safe and effective as daily carprofen. However, the monthly dosing regimen represents such a big step from the currently used approach of daily NSAID dosing, that Pfizer has decided to initiate the study before launching the product in order to closely monitor and manage the introduction of Trocoxil to the veterinary market.
Jolian Howell, Associate Director Companion Animal Marketing for Pfizer said: "A drug with such a unique dosing regimen should be introduced in a controlled and managed way, and this study is part of that commitment by Pfizer Animal Health."
This large post-approval study, conducted under veterinary control as a User Experience Study, will enable a similar comparison with carprofen to be made in a much larger patient population. In fact it will be sufficiently large to provide product-specific safety information, such as any differences in the incidence of side-effects.
The randomised, parallel group study is being conducted in more than 100 veterinary clinics throughout France, Germany and the UK. Each dog will receive up to 6 months of treatment during which time it will be assessed every month by the veterinary surgeon.
Trocoxil, a preferential COX-2 inhibitor, has a unique pharmacological profile which means that a single oral dose provides continuous pain relief for a whole month.
Jolian added: "This study will provide veterinary surgeons with an opportunity to experience the benefits of using Trocoxil to treat OA continuously over a period of months. It will also give them the opportunity to assess the benefits this offers the owner."
Veteran campaigner and RCVS Councillor Danny Chambers MRCVS (pictured right) has started a petition to George Eustice on change.org that: Future trade deals must not compromise animal welfare and public health.
The petition has gathered an impressive 21,984 signatures, of which Danny says that more than 500 are from veterinary surgeons.
Meanwhile VetPartners is calling on the retail and food service sector to give priority to British produce, even if future trade deals enable the import of foods produced to lower standards.
Ian Cure, farm director at VetPartners, is contacting the UK’s main retailers to discuss how they can support British farmers in the months and years to come. He has the backing of the clinical directors at each of the 28 farm or mixed practices within the group, which collectively look after the health and welfare of over 30% of the UK’s dairy population and 45% of the pig population.
“We are asking retailers to prioritise a range of Red Tractor certified produce at varying prices, while avoiding designating shelf space to imports of a lower quality. Likewise, the food service sector can choose to source from UK food supply chains.
“These sectors have a high level of influence, as consumers will pick from what is clearly available, which is why we see it as the best way to support our farmers.
“We are incredibly concerned about how the higher welfare and production standards in UK agriculture will be protected long term, given that MPs failed to enshrine that protection in law when voting against the recent amendment to the Agriculture Bill last month.
“Future trade deals to allow the import of cheap food from countries outside of the EU would be a step in the wrong direction, as our farmers will not be competing on an even playing field as they attempt to compete with countries with lower costs of production.”
However, Ian adds that this is not just a welfare issue: "If the UK livestock sector is forced to adopt practices that are frowned upon in Europe to compete, such as the American applications of hormone growth treatments and chlorinated chicken, we would be severely risking our local, lucrative European export market.
“While trade with countries such as the USA and Australia may have benefits from an economical perspective, the carbon emissions associated with longer distance transport of food is a real concern.
“We see it as imperative that higher welfare standards are maintained, while reducing the carbon footprint of our food supply – it's the right, sustainable thing to do. As MPs have let down the sector, we are now calling on retailers and the food service industry to back UK farming."
Bravecto Triuno is approved for the treatment of tick and flea infestations in dogs (Ctenocephalides felis, C. canis, Dermacentor reticulatus, Ixodes hexagonus, Ixodes ricinus, and Rhipicephalus sanguineus).
It is also approved for the treatment of infections with roundworms (adult stages of Toxocara canis and Toxascaris leonina) and hookworms (L4, immature adult (L5), and adult stages of Ancylostoma caninum and Uncinaria stenocephala), for the prevention of heartworm disease (caused by Dirofilaria immitis), and for the prevention of angiostrongylosis (by reduction of the level of infection with immature adult (L5) and adult stages of Angiostrongylus vasorum).
Victoria Miles, UK Companion Animal Director, MSD Animal Health, said: “With this latest formulation of Bravecto, MSD Animal Health is giving veterinarians and dog owners a greater range of convenient options for protecting their dog year-round from parasites, and all from the same trusted Bravecto portfolio.”
She added: “We see Bravecto Triuno as a great option for puppies that require a monthly wormer on top of protection against fleas and ticks.
"This also gives flexibility later on for the dog to remain with the Bravecto brand but be swapped onto a longer-duration flea and tick product with a wormer administered according to a veterinarian’s risk-based assessment.”
Bravecto Triuno is available as a flavoured chewable tablet indicated for dogs and puppies from 8 weeks of age and at least 1.27 Kg body weight and can be administered monthly to dogs at risk of infestation by multiple types of internal and external parasites.
It contains three anti-parasitic ingredients including fluralaner, which provides activity against ticks and fleas, moxidectin, which provides systemic activity against non-intestinal worms, and pyrantel, which provides activity against intestinal worms.
https://www.noahcompendium.co.uk/?id=-488423
All members of the practice team are invited to nominate their receptionist, as are members of the public. Nominations should highlight the dedication and effort the nominee demonstrates, and entries need to be in by the 31st January 2019.
BVRA founder Brian Faulkner MRCVS said: "Veterinary receptionists are as crucial to the success of a veterinary practice as any other role. They are first and last impression a client has of a veterinary practice and the association is keen to recognise and reward their unique contribution to the industry.
We’ve been astounded by how popular the BVRA has been since its launch one year ago with receptionists at every level of experience, reporting appreciation as well as the benefits of Accredited Veterinary Receptionist Award. It’s entirely appropriate that BVRA champions ‘best practice’ and therefore the BVRA’s Veterinary Receptionist of the Year Award will recognise their hard work."
Brian added: "We’re so grateful to all of our corporate sponsors in helping us get BVRA off the ground and grow. We are especially grateful to Feliway and Adaptil, sponsors of The Veterinary Receptionist of the Year Award. A motivated and inspired veterinary receptionist can be the difference between whether a client registers with your practice or not. So why not log onto the www.bvra.co.uk right now and nominate that receptionist who deserves to be acknowledged and celebrated?"
Three finalists will be chosen and invited to attend BVRA’s 2nd Annual congress on 16th March 2019 in Sutton Coldfield, where the winner will be announced.
To nominate your receptionist, visit: https://www.bvra.co.uk/Home/CPD.
The platform, which is available to Premier Pet Care Plan and Animal Healthcare clinics, is designed to help practices increase the number of sign-ups to health care plans.
Romain Regnier (pictured right), PVA’s Business Analyst Manager said: "The current situation has accelerated the need for a digital transformation.
"To help vet practices reach this goal, we have created a highly customisable digital sign-up solution, which mirrors the practice’s branding and can be used in communications to the customer, giving you more possibilities to promote your plans."
With a digital platform, practices can now encourage owners to sign up whilst waiting - socially distanced - outside, or from home.
Debbie Saunders, PVA’s Customer Experience Manager said: "It’s a two-pronged solution; reducing the impact that limited interactions with clients is having on health care plan signs ups and allowing practices to advertise their plans more efficiently.
We are encouraging practices to post about their new digital sign-up links on social media, so pet owners complete their forms anywhere. It will make a big difference to veterinary staff, reducing the amount of administrative pressure from plans but also allowing a direct call to action from advertising."
Each practice will be given unique urls, tiny urls and QR codes which link to the platform, alongside additional marketing materials. The marketing packs contain some customisable content, including social media assets, website banners and printable posters, all free to use to promote the new sign-up platform.
The digital sign-up platforms come with personalisation options, allowing practices to customise their webpage with their own logos, text, and branding, with the help of their PVA trainer.
If you are a Premier Pet Care Plan or Animal Healthcare clinic and are interested in integrating a digital sign-up form into your practice, contact your PVA trainer or call 0117 370 0300 .
The company says it recognises how frustrating it can be for veterinary surgeons if the owner doesn't recognise that their dog has a painful condition. This can be compounded by short consult times, leaving vets unable to fully communicate the implications and treatment options for the disease.
In the video, Zoe encourages vets to tailor their language to each case, in particular, using the language dog owners will use.
While undertaking her research Zoe noticed that many owners do not talk about OA in the same way that vets might; instead of referring to lameness or pain, many owners will refer to the actual physical signs of OA such as stiffness or communicate that their dog is slowing down.
Zoe has also warned that not all owners are convinced by visual demonstrations such as flexing and extending the dogs joints. Instead, she suggests encouraging the owner to get hands-on.
Zoe said: "Point out the visual changes suggestive of osteoarthritis that you can see, such as muscle loss, scuffed nails, and enlarged joints. And encourage them to have a look and a feel, comparing affected and unaffected joints. Hopefully, the owner may be more receptive to the conversation now they associate it with a symptom they can recognise."
Zoe says she also finds that many owners of older dogs often misinterpret the signs of OA as 'just old age' and may not be aware that the condition can be managed effectively with medication, the right exercise, diet and by making modifications in the home.
Elanco has also produced an OA management template which enables both the vet and the owner to create a tailored plan. It provides the owner with information to take away with them about how to modify their home, written in collaboration with Founder of Canine Arthritis Management, Hannah Capon.
Lastly, Zoe recommends a whole practice approach to becoming experts on OA, veterinary nurses in particular. She said: "Vet nurses often have great ideas about how to explain the condition in a way that owners understand. Better owner understanding of OA should lead to better adherence to treatment plans and ultimately better clinical outcomes."
To watch the video, click here.
To access the suite of assets Elanco has created for Onsior (which includes the management plan, social media posts for the practice, and infographic to help owners to spot the signs of OA) visit: www.myelanco.co.uk
The ideal Christmas present for a vet to give a child has just landed on my desk.
It's the Amazing ABC Adventure by Lorna Maxwell, out now in paperback from Long Barn Books and available on Amazon here.
Each letter of the alphabet begins an eclectic list of things to be found within a delightful illustration on the facing page. There's a strong animal theme throughout the book: everything from annoyed armadillos and affectionate alligators to worried wombats and yodelling yaks.
One of those books that it's a pleasure to read a child before bed. A steal at £5.79.
The Disciplinary Committee heard that Mrs Garfield had told a representative of the Retired Greyhound Trust (RGT) that she had possession of a greyhound called Lola, that she proposed keeping Lola living with her as an adoptee, and that she would not relinquish possession of Lola except to the RGT. This was despite the fact that, at the time of signing the adoption agreement, she had already given Lola to another charity named Greyhound Gap and that, as a result, her conduct was misleading and dishonest.
In considering the facts of the case, the Committee found the charges and all constituent parts proven and went on to consider whether this amounted to disgraceful conduct in a professional respect.
Judith Way, chairing the Committee and speaking on its behalf, said: "The end result of the respondent’s decisions and conduct meant that RGT was persuaded to pass lawful possession and ownership of the dog Lola to the respondent when it would not have agreed to do so had it been told the truth by her.
"In truth, the respondent was not going to adopt and re-home Lola herself. Instead the respondent’s plan and intention was that Lola should be passed on to a third party who had been recommended by a rival dog rescue charity for rehome and adoption."
Judith added: "The consequence was that a social media dispute broke out when the rival dog charity decided to attempt to take advantage of the erroneous belief of the respondent that a decision had been taken by RGT to put Lola to sleep. The publicity generated by the respondent’s erroneous belief… was obviously adverse…. The gravamen [seriousness] of the respondent’s dishonest conduct was that she set one dog rescue charity against another, caused them to spend publicly raised funds on a legal dispute about who should be allowed to retain Lola when those precious funds ought, instead, to have been spent on their charitable objectives."
The Committee judged that the charge and its parts constituted serious professional misconduct and went on to consider the sanction against Mrs Garfield.
In considering the proportionate sanction the Committee took into account both mitigating and aggravating factors. In terms of aggravating factors the Committee considered that the dishonesty was pre-meditated, that she accused members of a rescue charity of lying and demonstrated no or only minimal insight into her wrongdoing. In mitigation the Committee considered that Mrs Garfield had cooperated with the College in its investigations, that she had acted in the genuine belief that she was acting in the best interests of Lola and that her conduct did not put Lola at risk or cause her to suffer any adverse consequences as a result. The Committee also accepted the testimonials and positive evidence from colleagues.
However, the Committee decided that removal from the Register would be the only appropriate sanction.
Summing up Judith Way said: "The reputational consequences for RGT were potentially significant bearing in mind that it is a rescue organisation with some 57 or so branches across the country. All of these consequences, actual and potential, stem from the respondent’s premeditated act of dishonesty in relation to which the Committee considers she showed very limited insight prior to this disciplinary hearing, as she did during the course of this hearing.
"In the result, it is the conclusion and decision of this Committee that the only proper sanction that can be imposed in this case is that the respondent’s name should be removed from the Register.”
Mrs Garfield has 28 days from being informed of the Committee’s decision to appeal.
Eurovet Animal Health has announced that it is bringing a veterinary licensed vitamin K1 (phytomenadione) injectable preparation to the UK.
Eurovet says the new preparation, available from the wholesalers by Monday at the latest, will ensure that the previous supply problems of vitamin K1, will be overcome.
According to the company, the intravenous route is the only route to ensure a 100% bioavailability of vitamin K1 almost immediately and in a crisis situation is the best route of treatment. During anticoagulant poisoning, the coagulation factors are present in the body but are not functional. The faster vitamin K1 enters the blood flow, the quicker the coagulation function is restored.
Ruth Vernon, Technical Services Manager for Eurovet said: "We also plan to bring veterinary licenced vitamin K1 tablets to the UK market later in the year, allowing them to be ordered direct from veterinary wholesalers. The future continuity of supply represents a significant improvement on the current situation."
Anticoagulant rodenticide poisoning is the second most common query received by the VPIS. Alexander Campbell, Head of Service at VPIS, said: "The Veterinary Poisons Information Service receives well over 1000 telephone enquiries per annum from UK veterinary professionals seeking advice on how to manage potential and accidental exposures to anticoagulant rodenticides in a variety of animals - mainly pet dogs. Whilst most cases require basic assessment, first-aid and precautionary laboratory tests, an inevitable few develop serious intoxication and need long-term treatment. Vitamin K1 is a mainstay of therapy in these instances, and the availability of licensed veterinary-specific products in the UK is a major advance. Previously, preparations licensed for human use were often the only option when these could be sourced. Anything that ensures ready supply and facilitates speed of therapy for severe cases has to be welcomed."
There are over 500 anticoagulant rodent killing preparations available across Europe. They are available ready to use, as coated cereals, bait blocks, tracking powders, semolina formats or concentrates (which are reserved for professional use). Following cut backs in local council spending on pest control, the National Pest Technicians Association identified in a recent survey* that there is a 'worrying increase in poorly-managed DIY rodent control'.
*The NPTA National Rodent Survey 2009/2010